TGA

“Impressive” results in breast cancer drug trial

Drug approvals ‘rushed, based on limited data’

Access concerns for ‘game-changing’ covid therapy

Covid treatments for the immune compromised

New cancer drug approvals

Durvalumab indications extended by TGA
